For example, its effect is potentiated by adiposity: Stender et al. showed that homozygosity for PNPLA3-I148M variant was associated with hepatic steatosis in 18% of lean individuals compared with 84% in the very obese [56]. This evidence concerns the gene PNPLA3 and fatty liver disease.